Reference page — cumulative record through Monday, October 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Incus
Product reference — Incus by Lxc · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 18 | 18 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 9.9 | .0050 | 12 | 2 | 2 | 2 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): █▁▁
| Month | New CVEs |
|---|---|
| 2026-08 | 18 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-48749 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48750 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48752 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48753 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48755 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48769 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-63125 | 9.9 | 50.7 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48751 | 9.9 | 49.5 | CRITICAL | — | 2026-08-21 |
| CVE-2026-62867 | 9.9 | 42.8 | CRITICAL | — | 2026-08-21 |
| CVE-2026-63343 | 9.9 | 39.9 | CRITICAL | — | 2026-08-21 |
| CVE-2026-62941 | 9.9 | 37.1 | CRITICAL | — | 2026-08-21 |
| CVE-2026-62940 | 9.9 | 34.6 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48754 | 2.1 | 30.6 | LOW | — | 2026-08-21 |
| CVE-2026-48756 | 2.1 | 30.6 | LOW | — | 2026-08-21 |
| CVE-2026-62313 | 4.3 | 28.2 | MEDIUM | — | 2026-08-21 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-62313 | 4.3 | 28.2 | MEDIUM | — | 2026-08-21 |
| CVE-2026-48750 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48754 | 2.1 | 30.6 | LOW | — | 2026-08-21 |
| CVE-2026-47753 | 4.4 | 4.0 | MEDIUM | — | 2026-08-21 |
| CVE-2026-63125 | 9.9 | 50.7 | CRITICAL | — | 2026-08-21 |
| CVE-2026-62940 | 9.9 | 34.6 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48769 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48751 | 9.9 | 49.5 | CRITICAL | — | 2026-08-21 |
| CVE-2026-55622 | 7.7 | 25.9 | HIGH | — | 2026-08-21 |
| CVE-2026-48753 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-48749 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-62941 | 9.9 | 37.1 | CRITICAL | — | 2026-08-21 |
| CVE-2026-55621 | 7.7 | 25.9 | HIGH | — | 2026-08-21 |
| CVE-2026-48752 | 9.9 | 53.4 | CRITICAL | — | 2026-08-21 |
| CVE-2026-63343 | 9.9 | 39.9 | CRITICAL | — | 2026-08-21 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Lxc — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
